Biologics MTF Biologics and Centurion Therapeutics Partner to Expand Access to Advance Wound Care Technologies byTim AllenJune 13, 2024
Biologics Top Stories Kolosis BIO and MTF Biologics Forge Strategic Partnership to Enter Surgical Incision Market byJosh SandbergMay 31, 2023
Biologics MTF Biologics Unveils New Tissue Form: AlloPatch® Pliable Meshed – Acellular Human Reticular Dermal Allograft byJosh SandbergApril 17, 2023
Biologics Geistlich announces the dramatic expansion of their allograft portfolio – vallos® sets the pace for regeneration byJosh SandbergMarch 16, 2023
Biologics Top Stories Kolosis BIO and MTF Biologics Extend Exclusive Agreement byJosh SandbergFebruary 14, 2023
Biologics Extremities Spine Top Stories Orthofix Announces First Patient Implants with Legacy Demineralized Bone Matrix for Spine, Pelvic and Extremities Procedures byChris StewartOctober 13, 2022
Biologics Spine Top Stories Orthofix and MTF Biologics Recognized with 2022 Spine Technology Award for Virtuos Lyograft – a First-of-Its-Kind, Shelf-Stable and Complete Autograft Substitute for Spine and Orthopedic Procedures byJosh SandbergOctober 12, 2022
Biologics Spine Top Stories Orthofix Announces First Clinical Use of Virtuos Lyograft – a First-of-Its-Kind, Shelf-Stable and Complete Autograft Substitute for Spine and Orthopedic Procedures byChris StewartJuly 26, 2022
Biologics Spine Bone Biologics Enters into Supply Agreement with MTF Biologics for Demineralized Bone Matrix byJosh SandbergMarch 7, 2022
